14068-1-AP

antibody from Proteintech Group

Targeting: ARID3A BRIGHT, DRIL1

Western blot (Supportive data in Antibodypedia)

ELISA (Data presented on provider website)

Immunocytochemistry (Supportive data in Antibodypedia)

Immunoprecipitation (Data presented on provider website)

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

14068-1-AP

Provider

Proteintech Group

Proper citation

Proteintech Cat#14068-1-AP, RRID:AB_2060390

Product name

ARID3A antibody

Antibody type

Polyclonal

Description

ARID3A antibody (Cat. #14068-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, IP, WB, ELISA.

Reactivity

Human, Mouse

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application.

Ren X, Huang M, Weng W, Xie Y, Wu Y, Zhu S, Zhang Y, Li D, Lai J, Shen S, Lin J, Kuang M, Li X, Yu J, Xu L
Cell reports. Medicine 2023 Nov 21;4(11):101277

---

ARID3A plays a key regulatory role in palmitic acid-stimulated milk fat synthesis in mouse mammary epithelial cells.

Guo X, Qi H, Lin G, Yu J, Zhang M, Gao X
Cell biology international 2023 Jun;47(6):1106-1117

---

MiR-361-3p promotes tumorigenesis of osteosarcoma cells via targeting ARID3A.

Zhou D, Ji G, Wei G, Li Z, Yu N, Wang Y, Lin B, Zhang L, Yin Y
Tissue & cell 2022 Jun;76:101759

---

ARID3A promotes the chemosensitivity of colon cancer by inhibiting AKR1C3.

Li Y, Tang J, Li J, Du Y, Bai F, Yang L, Li X, Jin X, Wang T
Cell biology international 2022 Jun;46(6):965-975

---

ARID3A promotes the development of colorectal cancer by upregulating AURKA.

Tang J, Yang L, Li Y, Ning X, Chaulagain A, Wang T, Wang D
Carcinogenesis 2021 Apr 30;42(4):578-586

---

ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.

Yoon G, Park JY, Kim HJ, Choi GS, Kim JG, Kang BW, Kang MK, Seo AN
Anticancer research 2019 Jun;39(6):2845-2853

---

Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2.

Madison BB, Jeganathan AN, Mizuno R, Winslow MM, Castells A, Cuatrecasas M, Rustgi AK
PLoS genetics 2015 Aug;11(8):e1005408

---

High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.

Song M, Kim H, Kim WK, Hong SP, Lee C, Kim H
Annals of surgical oncology 2014 Dec;21 Suppl 4:S481-9

Western blot

Supportive validation

Submitted by

Proteintech Group (provider)

Main image

Experimental details

K-562 cells were subjected to SDS PAGE followed by western blot with 14068-1-AP(ARID3A antibody) at dilution of 1:1500

Sample type

cell line

Immunocytochemistry

Supportive validation

Submitted by

Proteintech Group (provider)

Main image

Experimental details

Immunofluorescent analysis of HepG2 cells, using ARID3A antibody 14068-1-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red). Blue pseudocolor = DAPI (fluorescent DNA dye).

Sample type

cell line

Immunohistochemistry

Supportive validation

Submitted by

Proteintech Group (provider)

Main image

Experimental details

Immunohistochemical of paraffin-embedded human colon cancer using 14068-1-AP(ARID3A antibody) at dilution of 1:100 (under 10x lens)

Sample type

tissue

Supportive validation

Submitted by

Proteintech Group (provider)

Main image

Experimental details

Immunohistochemical of paraffin-embedded human colon cancer using 14068-1-AP(ARID3A antibody) at dilution of 1:100 (under 40x lens)

Sample type

tissue